These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33588241)

  • 1. Synthesis, in-vitro evaluation, molecular docking, and kinetic studies of pyridazine-triazole hybrid system as novel α-glucosidase inhibitors.
    Moghimi S; Salarinejad S; Toolabi M; Firoozpour L; Esmaeil Sadat Ebrahimi S; Safari F; Madani-Qamsari F; Mojtabavi S; Faramarzi MA; Karima S; Pakrad R; Foroumadi A
    Bioorg Chem; 2021 Apr; 109():104670. PubMed ID: 33588241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
    Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
    Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green synthesis, inhibition studies of yeast α-glucosidase and molecular docking of pyrazolylpyridazine amines.
    Chaudhry F; Ather AQ; Akhtar MJ; Shaukat A; Ashraf M; Al-Rashida M; Munawar MA; Khan MA
    Bioorg Chem; 2017 Apr; 71():170-180. PubMed ID: 28259376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, in vitro evaluation, and molecular docking studies of novel hydrazineylideneindolinone linked to phenoxymethyl-1,2,3-triazole derivatives as potential α-glucosidase inhibitors.
    Shareghi-Boroujeni D; Iraji A; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M
    Bioorg Chem; 2021 Jun; 111():104869. PubMed ID: 33839583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents.
    Sayahi MH; Zareei S; Halimi M; Alikhani M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Faramarzi MA; Rastegar H; Taslimi P; Ibrahim EH; Ghramh HA; Larijani B; Mahdavi M
    Sci Rep; 2024 Jul; 14(1):15791. PubMed ID: 38982268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro and computational studies of 1,4-disubstituted 1,2,3-triazoles as potential α-glucosidase inhibitors.
    Jabeen F; Shehzadi SA; Fatmi MQ; Shaheen S; Iqbal L; Afza N; Panda SS; Ansari FL
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1029-1038. PubMed ID: 26725952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies.
    Avula SK; Khan A; Rehman NU; Anwar MU; Al-Abri Z; Wadood A; Riaz M; Csuk R; Al-Harrasi A
    Bioorg Chem; 2018 Dec; 81():98-106. PubMed ID: 30118991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
    Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
    Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, α-Glucosidase Inhibitory Activity and Molecular Docking Study of Chalcone Derivatives Bearing a 1H-1,2,3-Triazole Unit.
    Ardiansah B; Rohman N; Nasution MAF; Tanimoto H; Cahyana AH; Fadlan A; Ariyani T
    Chem Pharm Bull (Tokyo); 2023; 71(5):342-348. PubMed ID: 37121684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of α-glucosidase enzyme by 'click'-inspired pharmacophore framework 1,3,4-thiadiazole-1,2,3-triazole hybrids.
    Dhameja M; Kumar H; Kurella S; Singh R; Uma A; Gupta P
    Future Med Chem; 2023 Feb; 15(4):345-363. PubMed ID: 36942781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavone-1,2,3-triazole derivatives as potential α-glucosidase inhibitors: Synthesis, enzyme inhibition, kinetic analysis and molecular docking study.
    Dhameja M; Kumar H; Kurella S; Uma A; Gupta P
    Bioorg Chem; 2022 Oct; 127():106028. PubMed ID: 35868105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel pyridazine N-aryl acetamides: In-vitro evaluation of α-glucosidase inhibition, docking, and kinetic studies.
    Moghimi S; Toolabi M; Salarinejad S; Firoozpour L; Sadat Ebrahimi SE; Safari F; Mojtabavi S; Faramarzi MA; Foroumadi A
    Bioorg Chem; 2020 Sep; 102():104071. PubMed ID: 32688112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, α-glucosidase inhibitory activity, and molecular dynamic simulation of 6-chloro-2-methoxyacridine linked to triazole derivatives.
    Asadi M; Ahangari MM; Iraji A; Azizian H; Nokhbehzaim A; Bahadorikhalili S; Mojtabavi S; Faramarzi MA; Nasli-Esfahani E; Larijani B; Mahdavi M; Amanlou M
    Sci Rep; 2024 Jul; 14(1):17338. PubMed ID: 39069559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: a new class of α-glucosidase inhibitors.
    Iraji A; Shareghi-Brojeni D; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M
    Sci Rep; 2022 May; 12(1):8647. PubMed ID: 35606520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.